🔎 Trials Near Me

Beranda › Sindrom Down › Arizona

Uji klinis Sindrom Down di Arizona

7 studi untuk Sindrom Down mencari peserta di lokasi di Arizona.

Kota di Arizona

Teks studi resmi (Bahasa Inggris)

Endotype DIrected Treatment for OSA in Down Syndrome

  • University of Arizona, Tucson
Menerima pesertaFase 4
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07280468

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Banner Children's at Desert, Mesa
  • Phoenix Childrens Hospital, Phoenix
  • Banner University Medical Center - Tucson, Tucson
Menerima pesertaFase 2
Usia 1 hingga 30 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04546399

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

  • Phoenix Childrens Hospital, Phoenix
Menerima pesertaStudi observasional
Usia 6 hingga 39 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05702645

The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

  • Valley Perinatal Services, Phoenix
Menerima pesertaStudi observasional
Semua usia · Wanita · Diperbarui 12 Jun 2026 · NCT07643896

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • Barrow Neurological Institute, Phoenix
Menerima pesertaStudi observasional
Usia 25 hingga 55 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT04165109

Patterns of Neurodevelopmental Disorders

  • Rossignol Medical Center, Phoenix
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT06213090

Pediatric Down Syndrome Post-Approval Study

  • Phoenix Children's Hospital, Phoenix
Menerima peserta
Usia 13 hingga 18 · Semua jenis kelamin · Diperbarui 28 Feb 2025 · NCT06851338

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.